SEC Form D private-offering filing

Mediar Therapeutics, Inc.

Name: Mediar Therapeutics, Inc. - new SEC Form D private-offering filing, Boston, MA
Published: 2025-12-23

A new SEC Form D private-offering notice from Boston, MA, a $75,699,630 filer-stated offering target in Biotech. The source filing is one click away.

Mediar Therapeutics, Inc. site↗ Verified via SEC Form D

Clinical-stage biotech developing first-in-class antibody therapies to halt fibrosis by targeting the myofibroblast.

Filed 2025-12-23Filed to raise $75,699,630First money in 2025-12-10Raised so far $37,849,815HQ (as filed) Boston, MASector Biotech ✓Stage (inferred) GrowthCall status Call-ready

Source linked the Form D on EDGAR↗Website verified mediartx.com↗Named in the filing 9 executives & directors

Open this row on the live feed →More new filings in Massachusetts →More Biotech filings →

This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.